CXCL13 and primary central nervous system lymphoma: Rubenstein et al. recently evaluated the utility of CXCL13 (a mediator of B-cell migration) and IL-10 as diagnostic biomarkers with the ability to discriminate CNS lymphoma from other CNS [6•].